United States Pediatric Vaccines Market 2023 – 2027
- Report Code : DPI2010469
- Published On: Sep, 2020
- Category : Healthcare & Pharma
- Pages : 120
-
The United States pediatric vaccines market is projected to exceed US$ 15 Billion by 2027.
Growth in the United States pediatric vaccine market can be accredited to factors such as, increasing community acceptance, improved disease cognizance, growing government focus on vaccination programs, and increased government funding for vaccine development.
Report Scope:
• The Market Size of the United States Pediatric Vaccines Market with Seven Years Forecast
• The Market Size of the Polio, Hepatitis B, Hepatitis A, Diphtheria, Tetanus & Pertussis (DTaP), Haemophilus Influenzae Type B (HIB), Pneumococcal Disease, Measles, Mumps, and Rubella (MMR), Varicella / Chicken Pox, Rotavirus, Influenza Pediatric with Seven Years Forecast
• Detailed Market Share Assessment of the United States Pediatric Vaccines Market
• Covers a Complete Analysis of the United States Pediatric Vaccines Doses Administered with Seven Years Forecast
• Scrutinizes the United States Children Being Vaccinated with Pediatric Vaccines with Seven Years Forecast
• Delivers Inclusive Insights on the Latest Pricing Trends and Analysis of the United States Pediatric Vaccines
• Delivers a Comprehensive Outline of the Preventable Diseases and their Vaccines Available in the Market
• Detailed Insights into the Regulatory Framework of the United States Influenza Vaccines Market
• Delivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the United States Pediatric Vaccines Market
• A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Business Overview, and Recent Development
“United States Pediatric Vaccines Market 2020 - 2027” provides an exclusive tool for assessing the market, highlighting prospects, supporting strategic and positive decision–making. This report identifies that in this rapidly-evolving and competitive situation, up–to–date information and statistics is crucial to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on the United States pediatric vaccines market. The report also provides a clear insight into current and future developments of the United States pediatric vaccines market. Furthermore, this report provides a deep and thorough evaluation of the top pediatric vaccines by disease indication.
Based on disease indication, the top pediatric vaccines provide an in-depth analysis of the number of children being immunized, doses administered, market size, and analysis. The report provides historical market data for 2015 – 2019, and forecasts from 2020 till 2027.
An all-inclusive examination has been done on the pricing, distribution, demand, and preventable diseases and their vaccines available in the market.
Additionally, this up-to-date report describes a clear view of the regulatory framework of the United States pediatric vaccines market. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.
The report also analyses detailed profiles of innovative and leading players with information on business overview, companies’ vaccines portfolio, and the latest developments.
The Major Companies Dominating this Market for its Products, Services, and Continuous Product Developments are:
• Sanofi Pasteur
• Merck
• Pfizer
• Grifols
• GlaxoSmithKline (GSK)
Key Questions Addressed by the Report
• What is the current size of the overall pediatric vaccines market in the United States
• How much will this market be worth from 2020 to 2027
• Which pediatric vaccines provide the highest market share
• How many children being immunized with pediatric vaccines in the US during 2015 – 2027
• What are the key marketed pediatric vaccines available in the United States
• How many pediatric vaccine doses administered in the US during 2015 – 2027
• What are the major drivers of the United States pediatric vaccines market
• What are the major inhibitors of the United States pediatric vaccines market
• What is the regulatory framework in the United States pediatric vaccines market
• Who are the top market players What are their happenings, vaccines, current developments, and scenarios
• How is the market predicted to develop in the future
-
With tables and figures helping analyze worldwide United States Pediatric Vaccines market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1. Executive Summary
2. United States Pediatric Vaccines Market Analysis, 2015 – 2019 and Forecast, 2020 – 2027
3. United States Pediatric Vaccines Market Share and Y–o–Y Growth (%)
4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market4.1 Market Drivers
4.2 Market Inhibitors
5. United States Pediatric Vaccines Market – By Disease Indication (2015 – 2027)5.1 Polio
5.1.1 Doses Administered (Volume)
5.1.2 Number of Children Being Vaccinated (Volume)
5.1.3 Market Size and Forecast (Value)5.2 Hepatitis B
5.2.1 Doses Administered (Volume)
5.2.2 Number of Children Being Vaccinated (Volume)
5.2.3 Market Size and Forecast (Value)5.3 Hepatitis A
5.3.1 Doses Administered (Volume)
5.3.2 Number of Children Being Vaccinated (Volume)
5.3.3 Market Size and Forecast (Value)5.4 Diphtheria, Tetanus & Pertussis (DTaP)
5.4.1 Doses Administered (Volume)
5.4.2 Number of Children Being Vaccinated (Volume)
5.4.3 Market Size and Forecast (Value)5.5 Haemophilus Influenzae Type B (HIB)
5.5.1 Doses Administered (Volume)
5.5.2 Number of Children Being Vaccinated (Volume)
5.5.3 Market Size and Forecast (Value)5.6 Pneumococcal
5.6.1 Doses Administered (Volume)
5.6.2 Number of Children Being Vaccinated (Volume)
5.6.3 Market Size and Forecast (Value)
5.7 Measles, Mumps & Rubella (MMR)
5.7.1 Doses Administered (Volume)
5.7.2 Number of Children Being Vaccinated (Volume)
5.7.3 Market Size and Forecast (Value)
5.8 Varicella / Chicken Pox
5.8.1 Doses Administered (Volume)
5.8.2 Number of Children Being Vaccinated (Volume)
5.8.3 Market Size and Forecast (Value)
5.9 Rotavirus
5.9.1 Doses Administered (Volume)
5.9.2 Number of Children Being Vaccinated (Volume)
5.9.3 Market Size and Forecast (Value)5.10 Influenza Pediatric
5.10.1 Doses Administered (Volume)
5.10.2 Number of Children Being Vaccinated (Volume)
5.10.3 Market Size and Forecast (Value)
6. Preventable Diseases and their Vaccines Available in the Market
7. United States Pediatric Vaccines Pricing Trends and Analysis
8. Regulatory Framework of the United States Pediatric Vaccines Market
9. Key Companies Analysis9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Pediatric Vaccines Portfolio
9.1.3 Recent Development9.2 GlaxoSmithKline (GSK)
9.2.1 Business Overview
9.2.2 Pediatric Vaccines Portfolio
9.2.3 Recent Development9.3 Merck
9.3.1 Business Overview
9.3.2 Pediatric Vaccines Portfolio
9.3.3 Recent Development9.4 Pfizer
9.4.1 Business Overview
9.4.2 Pediatric Vaccines Portfolio
9.4.3 Recent Development9.5 Grifols
9.5.1 Business Overview
9.5.2 Pediatric Vaccines Portfolio
9.5.3 Recent Development
List of Tables:
Table 3–1: United States Pediatric Vaccines Market Share (Percent), 2015 – 2019
Table 3–2: United States Pediatric Vaccines Market Share Forecast (Percent), 2020 – 2027
Table 6–1: Preventable Diseases and their Vaccines Available in the Market
Table 7–1: United States Pediatric Vaccines Price, 2020 – 2021
Table 8–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
List of Figures:
Figure 2–1: United States Pediatric Vaccines Market (Million US$), 2015 – 2019
Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2020 – 2027
Figure 5–1: Polio Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–2: Polio Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–3: Number of Children Being Vaccinated with Polio Vaccines (in Million), 2015 – 2019
Figure 5–4: Number of Children Being Vaccinated with Polio Vaccines Forecast (in Million), 2020 –2027
Figure 5–5: Polio Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–6: Polio Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–7: Hepatitis B Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–8: Hepatitis B Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–9: Number of Children Being Vaccinated with Hepatitis B Vaccines (in Million), 2015 – 2019
Figure 5–10: Number of Children Being Vaccinated with Hepatitis B Vaccines Forecast (in Million), 2020 –2027
Figure 5–11: Hepatitis B Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–12: Hepatitis B Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–13: Hepatitis A Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–14: Hepatitis A Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–15: Number of Children Being Vaccinated with Hepatitis A Vaccines (in Million), 2015 – 2019
Figure 5–16: Number of Children Being Vaccinated with Hepatitis A Vaccines Forecast (in Million), 2020 –2027
Figure 5–17: Hepatitis A Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–18: Hepatitis A Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–19: DTaP Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–20: DTap Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–21: Number of Children Being Vaccinated with DTaP Vaccines (in Million), 2015 – 2019
Figure 5–22: Number of Children Being Vaccinated with DTaP Vaccines Forecast (in Million), 2020 –2027
Figure 5–23: DTaP Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–24: DTaP Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–25: HIB Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–26: HIB Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–27: Number of Children Being Vaccinated with HIB Vaccines (in Million), 2015 – 2019
Figure 5–28: Number of Children Being Vaccinated with HIB Vaccines Forecast (in Million), 2020 –2027
Figure 5–29: HIB Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–30: HIB Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–31: Pneumococcal Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–32: Pneumococcal Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–33: Number of Children Being Vaccinated with Pneumococcal Vaccines (in Million), 2015 – 2019
Figure 5–34: Number of Children Being Vaccinated with Pneumococcal Vaccines Forecast (in Million), 2020 –2027
Figure 5–35: Pneumococcal Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–36: Pneumococcal Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–37: MMR Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–38: MMR Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–39: Number of Children Being Vaccinated with MMR Vaccines (in Million), 2015 – 2019
Figure 5–40: Number of Children Being Vaccinated with MMR Vaccines Forecast (in Million), 2020 –2027
Figure 5–41: MMR Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–42: MMR Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–43: Varicella Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–44: Varicella Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–45: Number of Children Being Vaccinated with Varicella Vaccines (in Million), 2015 – 2019
Figure 5–46: Number of Children Being Vaccinated with Varicella Vaccines Forecast (in Million), 2020 –2027
Figure 5–47: Varicella Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–48: Varicella Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–49: Rotavirus Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–50: Rotavirus Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–51: Number of Children Being Vaccinated with Rotavirus Vaccines (in Million), 2015 – 2019
Figure 5–52: Number of Children Being Vaccinated with Rotavirus Vaccines Forecast (in Million), 2020 –2027
Figure 5–53: Rotavirus Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–54: Rotavirus Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–55: Influenza Pediatric Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–56: Influenza Pediatric Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–57: Number of Children Being Vaccinated with Influenza Pediatric Vaccines (in Million), 2015 – 2019
Figure 5–58: Number of Children Being Vaccinated with Influenza Pediatric Vaccines Forecast (in Million), 2020 –2027
Figure 5–59: Influenza Pediatric Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–60: Influenza Pediatric Vaccines Market Value Forecast (in Million US$), 2020 – 2027
-
The United States Pediatric Vaccines Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
As manufacturers prepare to scale up, United States Pediatric Vaccines companies must be clear and transparent about the impact of such volatility on the balance sheet.
During the projected year from 2024 to 2029, the United States Pediatric Vaccines Market is expected to grow at a CAGR of xx%.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the United States Pediatric Vaccines Market as well as its distribution among its players
In this highly competitive and rapidly evolving United States Pediatric Vaccines Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
